Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Circ Heart Fail. 2012 Aug 16;5(5):602–609. doi: 10.1161/CIRCHEARTFAILURE.112.966960

Figure 4. Risk Stratification in Patients with Heart Failure According to Tertiles of Cystatin C and BNP.

Figure 4

The risk of the combined outcome (death, myocardial infarction, stroke) increases from 12.3% in patients with both biomarkers in the lowest tertile to 44.8% in patients with both biomarkers in the highest tertile (p<0.0001).